Idiopathic pulmonary fibrosis with or without emphysema: A three-year multi-centre study

被引：0
|
作者：
Fu, Pin-Kuei [1 ]
Fang, Yu-Hung [2 ]
Hsieh, Yi-An [3 ]
Chen, Yen-Fu [4 ]
Chiu, Yu-Chi [5 ]
Lin, Yu-Ching [6 ]
Huang, Kuo-Tung [7 ]
Huang, Yung-Chia [5 ]
Wei, Yu-Feng [8 ]
Huang, Chien-Wen [3 ]
机构：
[1] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan
[2] Chang Gung Mem Hosp, Chiayi Branch, Dept Internal Med, Chiayi, Taiwan
[3] Asia Univ Hosp, Dept Internal Med, Taichung, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Pulm Med, Yun Lin Branch, Touliu, Yunlin, Taiwan
[5] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Pulm Med, Taoyuan, Taiwan
[6] Chang Gung Univ Sci & Technol, Chiayi Branch, Dept Resp Care, Chiayi, Taiwan
[7] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan
[8] I Shou Univ, E Da Canc Hosp, Dept Internal Med, Kaohsiung, Taiwan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP16-542
引用
收藏
页码：424 / 425
页数：2
相关论文
共 50 条
  • [1] Comparison of the efficacy of pirfenidone in patients with combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis without emphysema
    Gwon, Hye Ran
    Kim, Song Yee
    Park, Jong Sun
    Park, Moo Suk
    RESPIROLOGY, 2023, 28 : 358 - 358
  • [2] Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial
    Manzetti, Gian Marco
    Hosein, Karishma
    Cecchini, Matthew J.
    Kwan, Keith
    Abdelrazek, Mohamed
    Zompatori, Maurizio
    Rogliani, Paola
    Mura, Marco
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [3] Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial
    Gian Marco Manzetti
    Karishma Hosein
    Matthew J. Cecchini
    Keith Kwan
    Mohamed Abdelrazek
    Maurizio Zompatori
    Paola Rogliani
    Marco Mura
    BMC Pulmonary Medicine, 21
  • [4] Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study
    Amiot, Aurelien
    Serrero, Melanie
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Vuitton, Lucine
    Viennot, Stephanie
    Bouguen, Guillaume
    Abitbol, Vered
    Fumery, Mathurin
    Gagniere, Charlotte
    Bouhnik, Yoram
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (01) : 40 - 53
  • [5] Idiopathic Pulmonary Fibrosis With Emphysema: Evidence of Synergy Among Emphysema and Idiopathic Pulmonary Fibrosis in Smokers
    Mitchell, Patrick D.
    Das, Jeeban P.
    Murphy, David J.
    Keane, Michael P.
    Donnelly, Seamas C.
    Dodd, Jonathan D.
    Butler, Marcus W.
    RESPIRATORY CARE, 2015, 60 (02) : 259 - 268
  • [6] Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema
    Sato, Seijiro
    Koike, Terumoto
    Hashimoto, Takehisa
    Ishikawa, Hiroyuki
    Okada, Akira
    Watanabe, Takehiro
    Tsuchida, Masanori
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 22 (04) : 216 - 223
  • [7] Distribution of emphysema and fibrosis in idiopathic pulmonary fibrosis with coexisting emphysema
    Kinoshita, Yoshiaki
    Watanabe, Kentaro
    Ishii, Hiroshi
    Kushima, Hisako
    Fujita, Masaki
    Nabeshima, Kazuki
    HISTOPATHOLOGY, 2019, 74 (07) : 1103 - 1108
  • [8] Preliminary data of the risk stratification score (RISE) prospective, multi-centre, 3-year, validation trial in idiopathic pulmonary fibrosis
    Manzetti, G. M.
    Hosein, K.
    Cecchini, M. J.
    Kwan, K.
    Abdelrazek, M.
    Zompatori, M.
    Rogliani, P.
    Mura, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [9] Insights From A Multi-Centre Real Life Experience In Germany With Nintedanib For The Treatment Of Idiopathic Pulmonary Fibrosis
    Bonella, F.
    Kreuter, M.
    Hagmeyer, L.
    Neurohr, C.
    Keller, C.
    Kohlhaeufl, M.
    Mueller-Quernheim, J.
    Milger, K.
    Prasse, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [10] Nintedanib for the Idiopathic Pulmonary Fibrosis with Emphysema
    Krome, Susanne
    PNEUMOLOGIE, 2019, 73 (03):
12345